Trademark Overview
On Thursday, January 9, 2025, a trademark application was filed for DALHIRA with the United States Patent and Trademark Office. The USPTO has given the DALHIRA trademark a serial number of 98947905. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 9, 2025. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The DALHIRA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology